Pfizer Inc (NYSE:PFE)

41.68
Delayed Data
As of Jul 23
 +0.21 / +0.51%
Today’s Change
32.80
Today|||52-Week Range
43.08
+13.23%
Year-to-Date
PFE Regular Dividend: PFE will begin trading ex-dividend on 07/29/21 with a $0.39 dividend payable to shareholders of record as of 07/30/21.
Why Is Novo Nordisk Buying a Rare-Disease Candidate?
9:31am / MotleyFool.com - Paid Partner Content
Sicart Associates LLC Buys Campbell Soup Co, Guardant Health Inc, Merck Inc, Sells Barclays ...
Jul 23 / GuruFocus News - Paid Partner Content
3 Value Stocks to Buy for the Second Half of 2021
6:04am / MotleyFool.com - Paid Partner Content
Balasa Dinverno & Foltz Llc Buys iShares MSCI Intl Multifactor ETF, iShares MSCI USA ...
Jul 23 / GuruFocus News - Paid Partner Content
This News May Hand the Vaccine Market Over to Pfizer and Moderna
6:00am / MotleyFool.com - Paid Partner Content
Arvinas (ARVN), Pfizer Team up for Breast Cancer Therapy
Jul 23 / Zacks.com - Paid Partner Content
Why Moderna Stock Surged to a New All-Time High Today
Jul 23 / MotleyFool.com - Paid Partner Content
Will Pfizer (PFE) Beat Expectations This Earnings Season?
Jul 23 / Zacks.com - Paid Partner Content
GMO's 2021 Mid-Year Letter: Equity Allocation Strategies
Jul 23 / GuruFocus News - Paid Partner Content
Glaxo (GSK) to Report Q2 Earnings: What's in the Cards?
Jul 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close41.47
Today’s open41.04
Day’s range41.42 - 41.83
Volume21,609,212
Average volume (3 months)26,009,322
Market cap$225.9B
Data as of 5:00pm ET, 07/23/2021

Growth & Valuation

Earnings growth (last year)-40.76%
Earnings growth (this year)+66.04%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)-19.02%
P/E ratio25.1
Price/Sales4.95
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+5.63+2.36%
ABBVAbbVie+0.63+0.54%
NVSNovartis+0.52+0.57%
MRKMerck+1.01+1.32%
Data as of 4:28pm ET, 07/23/2021

Financials

Next reporting dateJuly 28, 2021
EPS forecast (this quarter)$0.97
Annual revenue (last year)$41.9B
Annual profit (last year)$9.6B
Net profit margin16.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts